Document is current
Any future updates will be listed below
-
Authors
Shibata, Naoki https://orcid.org/0000-0001-6748-1505
Kondo, Toru
Morimoto, Ryota
Kazama, Shingo
Sawamura, Akinori
Nishiyama, Itsumure
Kato, Toshiaki
Kuwayama, Tasuku
Hiraiwa, Hiroaki
Umemoto, Norio
Asai, Toru
Okumura, Takahiro
Murohara, Toyoaki
- License Information
-
More Information
Article History
Received: 27 July 2021
Accepted: 28 January 2022
First Online: 28 February 2022
Declarations
:
: TO has received research grants from Ono Pharmaceutical Co., Ltd., Bayer Pharmaceutical Co., Ltd., Daiichi-Sankyo Pharma Inc., and Amgen Astellas BioPharma K.K. outside the submitted work. TO received honorariums from Ono Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Novartis Pharma K. K., and Medtronic Japan Co., Ltd. TM received lecture fees from Bayel Pharmaceutical Co., Ltd., Daiichi-Sankyo Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Kowa Co., Ltd., MSD K. K., Mitsubishi Tanabe Pharma Co., Nippon Boehringer Ingelheim Co., Ltd., Novartis Pharma K. K., Pfizer Japan Inc., Sanofi-Aventis K. K., and Takeda Pharmaceutical Co., Ltd. TM received unrestricted research grant for Department of Cardiology, Nagoya University Graduate School of Medicine from Astellas Pharma Inc., Daiichi-Sankyo Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Kowa Co., Ltd., MSD K. K., Mitsubishi Tanabe Pharma Co., Nippon Boehringer Ingelheim Co., Ltd., Novartis Pharma K. K., Otsuka Pharma Ltd., Pfizer Japan Inc., Sanofi-Aventis K. K., Takeda Pharmaceutical Co., Ltd., and Teijin Pharma Ltd. The remaining authors have no conflicts of interest relevant to this article to disclose.
